The Role of Biosimilar Antibodies in Advancing Drug Discovery
Research-grade in vivo biosimilar antibodies provide a critical tool for scientists studying therapeutic mechanisms in disease models. Their high demand is fueled by the rapid growth of biopharmaceutical research, the need for cost-effective alternatives to commercial antibodies, and the expansion of immuno-oncology, neuroscience, and autoimmune disease research.